drugset / Trial / NCT02515396
Phase 1a Study in Healthy Smokers to Investigate the Effect With MMI-0100 on Airway Inflammation in Induced Sputum After Challenge With Inhaled Lipopolysaccharide
RandomizedCrossoverTriple-blindTreatment
Summary
A Phase 1a, randomized, placebo controlled, two-way crossover study is to determine the effect of inhaled MMI-0100 compared to placebo following LPS challenge on inflammatory markers.
Timeline
- Start
- 2015-07
- Primary completion
- 2016-03
- Completion
- 2017-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MMI-0100 | Protein / enzyme biologic | — | Inhaled |
Indications
No indication recorded.